Case Report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data

BACKGROUND: Vitiligo-like depigmentation is a common skin adverse event in patients receiving immunotherapy for malignant melanoma, but has been rarely reported in patients with non-melanoma malignancies. To better understand this immune-related adverse event, we reviewed a series of cases of immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Hui, Guo, Zheng, Wen, Xuejiao, Zeng, Xiaoli, Wu, Longqiu, Huang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881409/
https://www.ncbi.nlm.nih.gov/pubmed/36713515
http://dx.doi.org/10.3389/fonc.2022.1099108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881409/
https://www.ncbi.nlm.nih.gov/pubmed/36713515
http://dx.doi.org/10.3389/fonc.2022.1099108

Ejemplares similares